Advertisement
Advertisement
Exagen’s Growth Potential Amid ASP Challenges: A Positive Long-Term Investment Outlook
PremiumRatingsExagen’s Growth Potential Amid ASP Challenges: A Positive Long-Term Investment Outlook
10d ago
Exagen’s Strong Volume Growth and Market Penetration Support Buy Rating Despite Temporary ASP Setbacks
Premium
Ratings
Exagen’s Strong Volume Growth and Market Penetration Support Buy Rating Despite Temporary ASP Setbacks
10d ago
Exagen reports Q3 EPS (31c), consensus (16c)
Premium
The Fly
Exagen reports Q3 EPS (31c), consensus (16c)
10d ago
Exagen initiated with a Buy at B. Riley
PremiumThe FlyExagen initiated with a Buy at B. Riley
2M ago
Exagen’s Legal Challenges: Potential Risks to Financial Stability and Market Position
Premium
Company Announcements
Exagen’s Legal Challenges: Potential Risks to Financial Stability and Market Position
4M ago
Exagen Inc. Reports Record Revenue Amidst Growth Challenges
Premium
Company Announcements
Exagen Inc. Reports Record Revenue Amidst Growth Challenges
4M ago
Exagen Inc. Reports Record Q2 2025 Revenue
PremiumCompany AnnouncementsExagen Inc. Reports Record Q2 2025 Revenue
4M ago
Exagen’s Promising Financial Trajectory and Raised Price Target Amid Strong Performance and Strategic Growth Initiatives
Premium
Ratings
Exagen’s Promising Financial Trajectory and Raised Price Target Amid Strong Performance and Strategic Growth Initiatives
4M ago
Exagen upgraded to Overweight from Sector Weight at KeyBanc
Premium
The Fly
Exagen upgraded to Overweight from Sector Weight at KeyBanc
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100